Andrzej Hellmann

7.4k citations
87 papers · 6.1k · 4 hit papers · h-index 31

Impact in

  • Genetics top 0.2%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 0.5%
    • Chronic Myeloid Leukemia Treatments
    • Acute Myeloid Leukemia Research

Papers in

    • Chronic Lymphocytic Leukemia Research 55
    • Chronic Myeloid Leukemia Treatments 19
    • Acute Myeloid Leukemia Research 12
    • Multiple Myeloma Research and Treatments 6

Andrzej Hellmann

83 papers receiving 5.9k citations

Andrzej Hellmann's Hit Papers

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial 2018 · 355 citations
3550+3+7Years since publication4008001.2k

Peers

Andrzej Hellmann
Comparison fields: 5 of 95
  • Genetics 3.3k
  • Hematology 2.4k
  • Pathology and Forensic Medicine 2.2k
  • Immunology 1.2k
  • Oncology 955
Replace Farrukh Tauseef Awan with:
Farrukh Tauseef Awan United States
Judith Dierlamm Germany
Achille Ambrosetti Italy
Rudolf Schlag Germany
Valentin Goede Germany
Stefano Molica Italy
Preetesh Jain United States
Paula V. Marlton Australia
Marzia Varettoni Italy
Massimo Gentile Italy
Andrzej Hellmann relative to Farrukh Tauseef Awan United States Farrukh Tauseef Awan's profile →
Citations per field
00.5×1.6×
Farrukh Tauseef Awan · 1×
Citations per year

Countries citing papers authored by Andrzej Hellmann

Since Specialization
Citations

This map shows the geographic impact of Andrzej Hellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Hellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Hellmann more than expected).

Fields of papers citing papers by Andrzej Hellmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Hellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Hellmann. The network helps show where Andrzej Hellmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Andrzej Hellmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andrzej Hellmann Line = papers co-authored together Andrzej Hellmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Hit paper breakdown →
20151291
2 2010476
3
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Hit paper breakdown →
2018398
4
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
Hit paper breakdown →
2018355
5 2007320
6 2007301
7
Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo‐controlled trials
Hit paper breakdown →
2018290
8 2008222
9 2011219
10 2012218
11 2000194
12 2019181
13 2018121
14 2004111
15 201595
16 201683
17 201076
18 202172
19 201869
20 200758

About Andrzej Hellmann

Andrzej Hellmann is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Immunology, having authored 87 papers that have together received 6.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (55 papers), Lymphoma Diagnosis and Treatment (26 papers), Chronic Myeloid Leukemia Treatments (19 papers), Acute Lymphoblastic Leukemia research (17 papers), Immunodeficiency and Autoimmune Disorders (13 papers), Acute Myeloid Leukemia Research (12 papers), Multiple Myeloma Research and Treatments (6 papers) and Eosinophilic Disorders and Syndromes (6 papers). The work is most often cited by research in Genetics (3.3k citations), Hematology (2.4k citations), Pathology and Forensic Medicine (2.2k citations), Immunology (1.2k citations) and Oncology (955 citations). Andrzej Hellmann has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Tadeusz Robak, Jerzy Hołowiecki, Jiri Mayer, Geoffrey W Chan, Jan Andrzej Walewski, Jørgen Holm Petersen, Lars Møller Pedersen, Nedjad Losic, Ole Gadeberg and Mimi Folden Flensburg. Their work appears in journals such as Blood, European Journal Of Haematology, Leukemia, British Journal of Haematology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact